You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage IB mycosis fungoides/Sezary syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Myxoid Liposarcoma, Metastatic Round Cell Liposarcoma, Metastatic Synovial Sarcoma Trial in United States (Interferon

Active, not recruiting
Has Results
  • Metastatic Myxoid Liposarcoma
  • +15 more
  • Interferon Gamma-1b
  • +2 more
  • Palo Alto, California
  • +6 more
Aug 2, 2022

Mycosis Fungoides, Sezary Syndrome, Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8 Trial in Jacksonville (Pembrolizumab)

Recruiting
  • Mycosis Fungoides
  • +12 more
  • Pembrolizumab
  • Jacksonville, Florida
    Mayo Clinic in Florida
Mar 22, 2022

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

Active, not recruiting
  • Folliculotropic Mycosis Fungoides
  • +7 more
  • Extracorporeal Photopheresis
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
Feb 28, 2022

Mycosis Fungoides, Sezary Syndrome, Mycosis Fungoides/Sezary Syndrome Trial in Saint Louis (Tulmimetostat)

Not yet recruiting
  • Mycosis Fungoides
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 13, 2023

Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage III Mycosis Fungoides and Sezary Syndrome AJCC v8, Stage IV

Recruiting
  • Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
  • +2 more
  • Phoenix, Arizona
  • +11 more
Aug 6, 2022

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome Trial in United States (brentuximab vedotin)

Recruiting
  • Mycosis Fungoides
  • +2 more
  • brentuximab vedotin
  • Stanford, California
  • +7 more
Nov 3, 2022

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Sezary Syndrome, Mycosis Fungoides Trial in Stanford (Mogamulizumab, LD TSEBT)

Recruiting
  • Sezary Syndrome
  • Mycosis Fungoides
  • Stanford, California
    Stanford Cancer Center
Oct 19, 2022

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Madrid, Zürich (Atezolizumab)

Active, not recruiting
  • Lymphoma, T-Cell, Cutaneous
  • Mycosis Fungoides/Sezary Syndrome
  • Madrid, Spain
  • +1 more
Jul 1, 2022

Low-Dose Total Skin Electron Therapy in Treating Refractory or

Recruiting
  • Recurrent Mycosis Fungoides
  • +4 more
  • Quality-of-Life Assessment
  • Objective Grading of Skin Findings
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Dec 5, 2022

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome

Recruiting
  • Mycosis Fungoides
  • Non-Hodgkin's Lymphoma
    • Duarte, California
    • +12 more
    Jun 17, 2022

    Mapping Emotional Dynamics During Corticosteroid Treatment

    Recruiting
    • Emotions
    • Corticosteroids
    • Short daily questionnaire
    • Leiden, Zuid-Holland, Netherlands
      LUMC
    Aug 30, 2022

    Mycosis Fungoides, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous Trial in Worldwide (resminostat, Placebo)

    Active, not recruiting
    • Mycosis Fungoides
    • +2 more
    • Graz, Austria
    • +53 more
    Dec 12, 2022

    CTCL, Mycosis Fungoides, Sezary Syndrome Trial in New York (Ritlecitinib)

    Recruiting
    • CTCL
    • +2 more
    • New York, New York
      Icahn School of Medicine at Mount Sinai
    May 18, 2023

    Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome Trial in Ann Arbor (Pembrolizumab, Mogamulizumab)

    Not yet recruiting
    • Cutaneous T Cell Lymphoma
    • Fungoides Mycosis Sezary Syndrome
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    Jul 13, 2023

    Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)

    Recruiting
    • Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
    • chlormethine gel
    • Bordeaux, France
    • +1 more
    Aug 17, 2022

    Patients With Mycosis Fungoides and Sézary Syndrome.

    Recruiting
    • Mycosis Fungoides
    • Sezary Syndrome
    • Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.
    • Lund, Sweden
      Lund University Hospital
    May 21, 2021

    Folliculotropic Mycosis Fungoides, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides Trial in United

    Recruiting
    • Folliculotropic Mycosis Fungoides
    • +7 more
    • Durvalumab
    • +2 more
    • Duarte, California
    • +3 more
    Jan 12, 2023

    Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis

    Withdrawn
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides/Sezary Syndrome
    • Zürich, Switzerland
      UniversitaetsSpital Zurich - Division of Dermatology
    Aug 31, 2021

    Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

    Terminated
    • Mycosis Fungoides
    • +2 more
    • Naloxone Hydrochloride Lotion, 0.5%
    • Placebo Lotion
    • Little Rock, Arkansas
    • +15 more
    Oct 26, 2022

    Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Stage I Cutaneous T-cell

    Terminated
    Has Results
    • Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma
    • +13 more
    • Chicago, Illinois
      Northwestern University
    Jul 24, 2019